Skip to content
menu-icon-lq
close-icon-lq

Mycobacterium tuberculosis, drug resistance


Scheme information

Service
EQAS
Scheme
Mycobacterium tuberculosis, drug resistance
Service provider
Labquality
Accreditation
Not accredited
Status
Pilot in 2022, in production 2023
Target
Laboratories
Coverage
Analytical phase
Rounds
4
Distributions
Globally
Coordinators
Jaana Paakkanen
Expert
Silja Mentula

Products

5230 / Mycobacterium tuberculosis, rifampicin and isoniazid, nucleic acid detection
Samples: 2 simulated samples, 1 mL
Type: Physical sample
Examinations: Mycobacterium tuberculosis nucleic acid detection, rifampicin susceptibility and isoniazid susceptibility
Additional information:

Contact us

Jaana Paakkanen
EQA Coordinator
+358 9 8566 8200

Leave us a contact request